Later research utilizing an S1R-specific antibody confirmed a significant upregulation of S1R in certain cancer types, including breast, lung, and prostate cancers, while lower expression was observed in the corresponding normal tissues. The gene discussed is TMBIM4; the disease is prostate carcinoma.